metformin has been researched along with cholecystokinin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Zaman, Y; Aylwin, S | 1 |
Brønden, A; Christensen, M; Hansen, M; Holst, JJ; Knop, FK; Rehfeld, JF; Rohde, U; Sonne, DP; Toräng, S; Vilsbøll, T | 1 |
Rohde, U | 1 |
Albér, A; Brønden, A; Holst, JJ; Knop, FK; Rehfeld, JF; Rohde, U; Vilsbøll, T | 1 |
2 review(s) available for metformin and cholecystokinin
Article | Year |
---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Topics: Animals; Bariatric Surgery; Bile Acids and Salts; Cholecystokinin; Diabetes Mellitus, Type 2; Gastric Bypass; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glycated Hemoglobin; Humans; Incretins; Metformin; Obesity; Weight Loss | 2016 |
2 trial(s) available for metformin and cholecystokinin
Article | Year |
---|---|
Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses.
Topics: Adult; Blood Glucose; C-Peptide; Cholecystokinin; Double-Blind Method; Gallbladder; Gallbladder Emptying; Gastrins; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Organ Size; Ultrasonography; Young Adult | 2016 |
Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes.
Topics: Aged; Bile Acids and Salts; Blood Glucose; Cholecystokinin; Cross-Over Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gallbladder Emptying; Glucagon-Like Peptide 1; Humans; Male; Metformin; Middle Aged; Placebos | 2017 |